JESSICA ROBINSON: Open Payments
NPI 1215591748 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 39 payments from 12 companies in 2025. Trend: 2023 $569 · 2024 $677 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $276 |
| Amgen Inc. | 9 | $144 |
| Exact Sciences Corporation | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Lilly USA, LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| IBSA Pharma Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Wegovy, Cologuard Collection Kit, EVENITY, AIRSUPRA, Rybelsus, Ozempic, REPATHA, Symbravo.
Industry payments across TX — which companies pay providers there.
